secwatch / observer
8-K filed April 21, 2026, 7:59 PM ET ticker SER CIK 0001708599
leadership confidence high sentiment neutral materiality 0.35

Serina appoints CTO, raises CEO salary to $500K, amends bylaws for Co-Chairs

Serina Therapeutics, Inc.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Serina Therapeutics, Inc.: Amended and restated bylaws to include provisions relating to appointment and authority of Co-Chairs of the Board of Directors, and conforming updates (effective 2026-04-15).

Change
bylaw amendment
Effective
2026-04-15
Exact text from the filing
On April 15, 2026, the Board of Directors of the Company approved and adopted amended and restated bylaws of the Company (the " Bylaws "), effective immediately. The Bylaws include provisions relating to the appointment of Co-Chairs of the Board of Directors, including provisions clarifying that special meetings of stockholders may be called by the Chair or any Co-Chair, that the Chair or any Co-Chair may preside at meetings of stockholders and meetings of the Board of Directors, and that each Co-Chair has the same authority and powers as the Chair of the Board and may act independently of any other Co-Chair, subject to coordination expectations set forth in the Bylaws.
View on SEC.gov

77 governance changes filed in the last 30 days. Browse all governance changes →

Serina Therapeutics, Inc. filing history →

Source: SEC EDGAR
accession 0001708599-26-000027
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.